Virologic, immunologic and clinical status of HIV infection and treatment of HIV-infected patients with and those without hepatotoxicity after receiving trimethoprim/sulfamethoxazole.

Note: 1. Data represent the median value (range) for continuous variables and the number of cases (%) for categorical variables. N indicates the number of patients being tested.2. *Two patients (4.26%) in the hepatotoxicity group and 18 patients (13.43%) in the control group were receiving nevirapine.Abbreviations: CMV, cytomegalovirus; cART, combination antiretroviral therapy; ICU, intensive care unit; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitor.Virologic, immunologic and clinical status of HIV infection and treatment of HIV-infected patients with and those without hepatotoxicity after receiving trimethoprim/sulfamethoxazole.